Nifty Pharma Index
NIFTY PHARMANifty Pharma Index
NIFTY PHARMA
Price Chart
Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.92 | 5.87 | 0.61% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.76% | 20 | — |
About Index
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return0.03% | 0.03% | 0.03% | 100.00% | Free float Mcap777.85 Weight100.00% | |
Abbott India LtdABBOTINDIA 0.01% Return attribution0.00% | 0.01% | 0.00% | 2.00% | 15.58 Weight2.00% | |
Alkem Laboratories LtdALKEM 0.16% Return attribution-0.00% | 0.16% | -0.00% | 2.94% | 22.90 Weight2.94% | |
Aurobindo Pharma LtdAUROPHARMA 0.49% Return attribution-0.03% | 0.49% | -0.03% | 5.43% | 42.21 Weight5.43% | |
Biocon LtdBIOCON 0.59% Return attribution-0.01% | 0.59% | -0.01% | 2.13% | 16.61 Weight2.13% | |
Zydus Lifesciences LtdZYDUSLIFE 0.06% Return attribution-0.00% | 0.06% | -0.00% | 3.54% | 27.51 Weight3.54% | |
Cipla LtdCIPLA 0.83% Return attribution0.09% | 0.83% | 0.09% | 11.33% | 88.10 Weight11.33% | |
Dr Reddy's Laboratories LtdDRREDDY 0.05% Return attribution0.01% | 0.05% | 0.01% | 10.11% | 78.68 Weight10.11% | |
Divi's Laboratories LtdDIVISLAB 0.65% Return attribution0.05% | 0.65% | 0.05% | 8.43% | 65.60 Weight8.43% | |
Glenmark Pharmaceuticals LtdGLENMARK 0.58% Return attribution0.02% | 0.58% | 0.02% | 3.05% | 23.69 Weight3.05% | |
Granules India LtdGRANULES 2.14% Return attribution-0.03% | 2.14% | -0.03% | 1.18% | 9.20 Weight1.18% | |
IPCA Laboratories LtdIPCALAB 0.27% Return attribution-0.01% | 0.27% | -0.01% | 2.42% | 18.86 Weight2.42% | |
J B Chemicals and Pharmaceuticals LtdJBCHEPHARM 0.15% Return attribution-0.00% | 0.15% | -0.00% | 1.76% | 13.71 Weight1.76% | |
Laurus Labs LtdLAURUSLABS 0.01% Return attribution-0.00% | 0.01% | -0.00% | 2.20% | 17.14 Weight2.20% | |
Lupin LtdLUPIN 1.24% Return attribution-0.09% | 1.24% | -0.09% | 6.91% | 53.75 Weight6.91% | |
Natco Pharma LtdNATCOPHARM 1.66% Return attribution-0.03% | 1.66% | -0.03% | 1.72% | 13.35 Weight1.72% | |
Sanofi India LtdSANOFI 0.36% Return attribution-0.00% | 0.36% | -0.00% | 0.85% | 6.65 Weight0.85% | |
Sun Pharmaceutical Industries LtdSUNPHARMA 0.04% Return attribution-0.01% | 0.04% | -0.01% | 24.92% | 193.87 Weight24.92% | |
Torrent Pharmaceuticals LtdTORNTPHARM 0.27% Return attribution0.01% | 0.27% | 0.01% | 4.27% | 33.21 Weight4.27% | |
Gland Pharma LtdGLAND 1.48% Return attribution0.03% | 1.48% | 0.03% | 1.82% | 14.15 Weight1.82% | |
Mankind Pharma LtdMANKIND 1.16% Return attribution0.03% | 1.16% | 0.03% | 2.97% | 23.09 Weight2.97% |
ETFs tracking this Index
There are no ETFs tracking this index. Events
Dividends
Corp. Actions
Announcements
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Upcoming Dividends
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 13, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Past Dividends
Cash DividendNATCOPHARM
NATCOPHARMEx DateEx DateAug 23, 2024
Dividend/Share
₹3.00
Ex DateEx Date
Aug 23, 2024
Cash DividendGLAND
GLANDEx DateEx DateAug 16, 2024
Dividend/Share
₹20.00
Ex DateEx Date
Aug 16, 2024
Cash DividendJBCHEPHARM
JBCHEPHARMEx DateEx DateAug 14, 2024
Dividend/Share
₹6.75
Ex DateEx Date
Aug 14, 2024
Cash DividendALKEM
ALKEMEx DateEx DateAug 9, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Aug 9, 2024
Cash DividendIPCALAB
IPCALABEx DateEx DateAug 6, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Aug 6, 2024
News & Opinions
No red flag in India but a period of extended low returns, or a pullback likely: Vikash Kumar Jain
2 days ago•Economic Times
Havells To Ranbaxy, Indian Companies Often Mistaken For Foreign MNCs - News18
2 days ago•News18
Dharmesh Shah on 2 top stock recommendation from pharma sector
2 days ago•Economic Times
Alembic Pharma gets USFDA nod for generic product
3 days ago•Economic Times
Stock market update: Nifty Pharma index falls 0.12%
3 days ago•Economic Times
This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lesson
3 days ago•Economic Times
Alembic Pharma shares jump 5% after USFDA approval; check details here
3 days ago•Business Standard
